FDA Advisory Committee to review Johnson & Johnson's (JNJ) COVID-19 vaccine on Feb 26th

Go back to FDA Advisory Committee to review Johnson & Johnson's (JNJ) COVID-19 vaccine on Feb 26th
Johnson & Johnson (NYSE: JNJ) Delayed: 170.27 +1.77 (1.05%)
Previous Close $168.50    52 Week High $126.07 
Open $169.90    52 Week Low $94.28 
Day High $171.53    P/E 35.40 
Day Low $169.23    EPS $4.81 
Volume 8,356,853